Cedars-Sinai Heart Institute launches stem cell therapy research clinic for cardiac patients
October 5, 2014
The Cedars-Sinai Heart Institute has announced the opening of a research clinic for evaluation of patients with heart and vascular disease as participants in stem cell therapy studies.
The Heart Institute Regenerative Medicine Clinic, will evaluate the potential benefits of stem cells for the repair of diseased or damaged CV tissue and match patients with appropriate clinical trials. The clinic is the first of its kind within a major US academic medical center, according to a press release. Eduardo Marbán, MD, PhD, director of the Heart Institute, and Timothy Henry, MD, director of the Institute’s cardiology division, will lead the new facility.
“Our goal is to help make stem cells a regular treatment option for heart disease,” Henry said in the release. “Right now, many patients with advanced heart disease have limited treatment options. Stem cells offer not only hope but a real chance of a game-changing treatment.”
The clinic offers consulting services for potential investigative stem cell therapy patients with heart or vascular disease. Physicians will assess patients willing to participate in stem cell trials at Cedars-Sinai, as well as those willing to travel to other facilities nationwide, according to the release. In cases where patients travel to other institutions, Cedars-Sinai will work with the investigators to expedite referrals and transfer of medical records.
“Patients who have battled HF, heart attacks and severe hypertension for years might not be aware of new options that could improve their health and quality of life,” Marbán said in the release. “Not every patient will find a suitable stem cell clinical trial, but we are focused on finding each patient the most advanced treatment for their disease.”
October 5, 2014
The Cedars-Sinai Heart Institute has announced the opening of a research clinic for evaluation of patients with heart and vascular disease as participants in stem cell therapy studies.
The Heart Institute Regenerative Medicine Clinic, will evaluate the potential benefits of stem cells for the repair of diseased or damaged CV tissue and match patients with appropriate clinical trials. The clinic is the first of its kind within a major US academic medical center, according to a press release. Eduardo Marbán, MD, PhD, director of the Heart Institute, and Timothy Henry, MD, director of the Institute’s cardiology division, will lead the new facility.
“Our goal is to help make stem cells a regular treatment option for heart disease,” Henry said in the release. “Right now, many patients with advanced heart disease have limited treatment options. Stem cells offer not only hope but a real chance of a game-changing treatment.”
The clinic offers consulting services for potential investigative stem cell therapy patients with heart or vascular disease. Physicians will assess patients willing to participate in stem cell trials at Cedars-Sinai, as well as those willing to travel to other facilities nationwide, according to the release. In cases where patients travel to other institutions, Cedars-Sinai will work with the investigators to expedite referrals and transfer of medical records.
“Patients who have battled HF, heart attacks and severe hypertension for years might not be aware of new options that could improve their health and quality of life,” Marbán said in the release. “Not every patient will find a suitable stem cell clinical trial, but we are focused on finding each patient the most advanced treatment for their disease.”